According to a story in the Boston Globe, Johnson & Johnson has appointed Bayer executive Sandra E. Peterson to oversee the company’s troubled consumer health and manufacturing operations.
The move is an attempt by Alex Gorsky, who became CEO of Johnson & Johnson in April, to address a host of quality, legal and ethical problems involving products and sales practices.
Those problems include what the article characterizes as “an eye-popping series of ...
continue reading...
Dr. John Howard, director of the National Institute for Occupational Safety and Health, is expected to soon issue a final rule on which cancers will be covered under the James Zadroga 9/11 Health and Compensation Act, according to an article in Newsday.
The Zadroga law, enacted January 2011, sets aside $2.8 billion to compensate people made ill by exposure to toxins at the site of the 2001 World Trade Center terrorist ...
continue reading...
On the first day of trial, Johnson & Johnson settled a lawsuit centering on complaints that its antipsychotic drug Risperdal caused a male plaintiff to grow breasts, Bloomberg reports. The terms of the settlement are confidential.
It was the first of about 130 lawsuits alleging that Risperdal caused young males to grow breasts. An additional 290 allege other personal injuries caused by the drug.
A lawyer for the plaintiff claimed he suffered ...
continue reading...
According to a report in the Belfast Telegraph, a 33-year-old woman who had been taking a birth control pills died suddenly after developing a blood clot in her lungs.
The story quotes a pathologist as saying that the woman died of a pulmonary venous thromboembolism, or a massive clot that traveled to her lungs, in association with a contraceptive pill. Genetics and the pill were both factors, the doctor said.
A family ...
continue reading...
A report in USA Today concerns the legal action by hundreds of plaintiffs who used the blood-thinner Pradaxa, stating that it may amount to “the country’s next blockbuster civil settlement.”
The U.S. Food and Drug Administration approved Pradaxa, manufactured by German pharmaceutical giant Boehringer Ingelheim, in 2010. At the time, it was promoted as the first replacement for the commonly used blood thinner warfarin, known by the brand ...
continue reading...According to the Wall Street Journal, the U.S. Food and Drug Administration has issued a warning about more than 900 reported problems from inferior vena cava, or IVC filters, meant to catch blood clots.
Although the FDA didn’t detail the number of reports by manufacturer, the Wall Street Journal says, a separate report published in the Archives of Internal Medicine found problems associated with two types of filters ...
continue reading...
